Di Mario F, Dotto P, Vianello F, Germanà B, Grassi S A, Del Favero G, Faggian D, Plebani M, Naccarato R
Istituto di medicina interna, Cattedra malattie apparato digerente, Università degli studi di Padova.
Acta Gastroenterol Belg. 1993 Mar-Apr;56(2):223-8.
Aim of the present study has been to investigate the possible modifications of peptic secretion after a period with H2 blockers and omeprazole, evaluating in the same patient pepsinogen group A levels in gastric mucosa and pepsin in gastric juice. 54 active duodenal ulcer were studied: during an upper gastrointestinal endoscopy a sample of gastric juice and one fundus biopsy were taken before and after four weeks 300 mg/daily ranitidine (23 patients), 40 mg/daily famotidine (7 patients), 300 mg/daily nizatidine (12 patients) therapy and 40 mg/daily omeprazole (12 patients) therapy.
H2-blockers and omeprazole treatment determines a non statistically significant decrease of pepsin in gastric juice and in pepsinogen group A in gastric mucosa.
本研究的目的是调查在使用H2阻滞剂和奥美拉唑一段时间后消化液分泌可能发生的变化,在同一患者中评估胃黏膜中胃蛋白酶原A水平和胃液中的胃蛋白酶。研究了54例活动性十二指肠溃疡患者:在进行上消化道内镜检查时,在接受四周每日300毫克雷尼替丁(23例患者)、每日40毫克法莫替丁(7例患者)、每日300毫克尼扎替丁(12例患者)治疗以及每日40毫克奥美拉唑(12例患者)治疗之前和之后采集胃液样本和一份胃底活检样本。
H2阻滞剂和奥美拉唑治疗使胃液中的胃蛋白酶以及胃黏膜中的胃蛋白酶原A出现非统计学显著下降。